CI logo

The Cigna Group (CI)

$295

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on CI

Market cap

$77.95B

EPS

24.17

P/E ratio

11.6

Price to sales

0.26

Dividend yield

2.115%

Beta

0.290466

Price on CI

Previous close

$298.28

Today's open

$296.04

Day's range

$294.12 - $299.54

52 week range

$239.51 - $316.27

Profile about CI

CEO

David M. Cordani

Employees

67700

Headquarters

Bloomfield, CT

Exchange

New York Stock Exchange

Shares outstanding

264240486

Issue type

Common Stock

CI industries and sectors

Healthcare

Medical Service Plans

News on CI

Analysts Estimate Cigna (CI) to Report a Decline in Earnings: What to Look Out for

Cigna (CI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

news source

Zacks Investment Research • 6 hours ago

news preview

The Cigna Group Declares Quarterly Dividend

BLOOMFIELD, Conn., Oct. 28, 2026 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.56 per share of its common stock, payable on December 17, 2026, to shareholders of record as of the close of business on December 3, 2026.

news source

PRNewsWire • Oct 28, 2026

news preview

Why Cigna (CI) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

news source

Zacks Investment Research • Oct 27, 2026

news preview

AM Best Assigns Credit Ratings to TMHCC (CI) Insurance SPC Ltd.

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned a Financial Strength Rating of A (Excellent) and a Long-Term Issuer Credit Rating of “a” (Excellent) to TMHCC (CI) Insurance SPC Ltd. [TMHCC (CI) or the company] (Cayman Islands). The outlook assigned to these Credit Ratings (ratings) is stable.The ratings reflect TMHCC (CI)'s balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, neutral business profile and appropriate enterprise risk ma.

news source

Business Wire • Oct 26, 2026

news preview

Here's Why Cigna (CI) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

news source

Zacks Investment Research • Oct 14, 2026

news preview

The Cigna Group's Third Quarter 2026 Earnings Release Details

BLOOMFIELD, Conn., Oct. 9, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its third quarter 2026 financial results on Thursday, November 5, 2026, and will host a conference call the same day.

news source

PRNewsWire • Oct 9, 2026

news preview

Cigna Healthcare Introduces Health Sense To Connect Guidance, Benefits and Clinical Support Around Each Person, Improving Affordability and Outcomes

By connecting information about each person's health, care and coverage, Health Sense℠ helps people receive continuous personalized support, make informed decisions and act sooner Projected to reduce inefficient health care spending by 10% by 2030, improving affordability for employers and customers alike. Watch a demonstration of the new Health Sense customer experience.

news source

PRNewsWire • Oct 6, 2026

news preview

Here's Why Cigna (CI) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

news source

Zacks Investment Research • Oct 6, 2026

news preview

The Cigna Group (CI) Analyst/Investor Day Transcript

The Cigna Group (CI) Analyst/Investor Day Transcript

news source

Seeking Alpha • Oct 1, 2026

news preview

Cigna: Deeply Undervalued With Expected Double-Digit EPS Growth Ahead

Cigna is rated a 'Strong Buy' for its compelling value, robust earnings growth, and capital returns at a forward P/E of 8.9x. CI posted strong Q2 2026 results, raised full-year EPS guidance, and targets 10–14% annual EPS growth through 2030, driven by AI and specialty pharmacy. CI's asset-light model, expanding specialty pharma presence, and aggressive share buybacks support high-teens total return potential annually.

news source

Seeking Alpha • Oct 1, 2026

news preview

¹ Disclosures

Get started with M1

Invest in The Cigna Group

Open an M1 investment account to buy and sell The Cigna Group commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in CI on M1